Chen-Chi Wang1,2,3, Shih-An Liu1,3, Shang-Heng Wu3, Wen-Jiun Lin3, Rong-San Jiang1,3,4, Lily Wang5. 1. School of Medicine, National Yang-Ming University, Taipei, Taiwan. 2. School of Speech Language Pathology and Audiology, Chung Shan Medical University, Taichung, Taiwan. 3. Department of Otolaryngology-Head and Neck Surgery, Taichung Veterans General Hospital, Taichung, Taiwan. 4. School of Medicine, Chung Shan Medical University, Taichung, Taiwan. 5. Department of Radiation Oncology, Taichung Veterans General Hospital, Taichung, Taiwan.
Abstract
BACKGROUND: Transoral robotic surgery (TORS) for early glottic cancer has been reported, but the issue of anterior commissure involvement has seldom been addressed. Therefore, the purpose of this study was to preliminarily report the treatment results of TORS in this disease entity. METHODS: Eight patients with T1 and T2 glottic carcinoma with anterior commissure involvement were selected to receive TORS. The clinical parameters, including rates of adjuvant radiotherapy (RT), survivals, as well as organ and function preservation, were retrospectively analyzed. RESULTS: TORS was successfully performed in all patients without temporary tracheostomy. There were no major complications and no patient received adjuvant RT to the larynx after surgery. With a mean follow-up of 40 months, all patients survived with their larynx preserved and no local recurrence, tracheostomy, or tube feeding dependence. CONCLUSION: TORS is a feasible approach for selected patients with early T classification glottic carcinoma with anterior commissure involvement. The preliminary oncologic and functional outcomes are satisfactory.
BACKGROUND: Transoral robotic surgery (TORS) for early glottic cancer has been reported, but the issue of anterior commissure involvement has seldom been addressed. Therefore, the purpose of this study was to preliminarily report the treatment results of TORS in this disease entity. METHODS: Eight patients with T1 and T2 glottic carcinoma with anterior commissure involvement were selected to receive TORS. The clinical parameters, including rates of adjuvant radiotherapy (RT), survivals, as well as organ and function preservation, were retrospectively analyzed. RESULTS:TORS was successfully performed in all patients without temporary tracheostomy. There were no major complications and no patient received adjuvant RT to the larynx after surgery. With a mean follow-up of 40 months, all patients survived with their larynx preserved and no local recurrence, tracheostomy, or tube feeding dependence. CONCLUSION:TORS is a feasible approach for selected patients with early T classification glottic carcinoma with anterior commissure involvement. The preliminary oncologic and functional outcomes are satisfactory.
Authors: Jérôme R Lechien; Robin Baudouin; Marta P Circiu; Carlos M Chiesa-Estomba; Lise Crevier-Buchman; Stephane Hans Journal: Eur Arch Otorhinolaryngol Date: 2022-06-22 Impact factor: 3.236